Santos-Briz A, Canueto J, Carmen SD, Barrios B, et al. Value of PD-L1, PD-1, and CTLA-4 Expression in the Clinical Practice as Predictors of Response to Nivolumab and Ipilimumab in Monotherapy in Patients With Advanced Stage Melanoma. Am J Dermatopathol 2020;Publish Ahead of Print.
PMID: 33395045